Showing 1 - 1 results of 1 for search 'Ludwig Hammel', query time: 0.01s
Refine Results
-
1
Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spon... by Xenofon Baraliakos, Denis Poddubnyy, Ludwig Hammel, Marvin Heyne, Justyna Veit, Claudia Jentzsch
Published 2020-09-01
Article